Trial Profile

A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 07 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Autologous-cancer vaccine-Vaccinogen (Primary)
Indications Colon cancer
Focus Registrational; Therapeutic Use
Acronyms ACTIVE
Sponsors Vaccinogen

Most Recent Events

14 May 2015 Status changed from planning to recruiting as reported by ClinicalTrials.gov record.
23 Feb 2015 New trial record
17 Feb 2015 Enrolment is expected to be initiated within 60 days of obtaining adequate funding, according to a Vaccinogen media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com